Search

everythinglearnresearchcommunity

for

Search:↓

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth, suggesting that blocking its receptor could potentially treat hair loss.

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth and could be a target for treating hair loss.

The PTGER2 gene is highly active in Cashmere goat skin and its activity changes with the hair growth cycle.

Higher levels of the DP2 receptor may lead to hair loss.

Prostaglandin D2 blocks new hair growth after skin injury through the Gpr44 receptor.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Human scalp hair follicles have PGE2 and its receptors, which might affect hair growth.

LPA3 is crucial for embryo implantation and links LPA to prostaglandin signaling.

A substance called 15-deoxy prostaglandin J2 can cause hair follicle cells to die, which might explain how prostaglandin D2 can lead to hair loss.

Prostaglandin E2 affects human platelet activity in complex ways that could lead to personalized heart disease treatments.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Prostaglandin D₂ might be targeted for new male pattern baldness treatments.

A protein called HMGB1 helps hair grow by affecting prostaglandin metabolism.

Early exposure to germs may protect against autoimmune diseases, lack of sex increases alcohol preference in fruit flies, a potential baldness treatment could involve blocking a specific receptor, skin memory cells help prevent re-infection, high-fat diets can affect brain cells related to weight, and the link between social status, stress, and heart disease in primates is unclear.

Group a wide range of chemicals, not just phthalates, for assessing risks to male reproductive health.

CRTH2 antagonists might be useful for treating many conditions because they play a role in immune and inflammation responses.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Hair loss can be treated with common methods like minoxidil and finasteride, but new potential treatments include growth factors, cytokines, and platelet-rich plasma injections.

The conclusion suggests that focusing on certain cellular pathways may improve the prevention and repair of hair loss caused by radiotherapy.

Prostaglandins and the enzyme AKR1C3 could play a role in skin cancer and hair loss, and further research is needed to understand these mechanisms.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

IGF-1R may play a role in female hair loss and could be a treatment target.

These drugs raise prostaglandin-like material in dog blood, possibly causing blood vessel widening.

Low doses of BPA can increase prostate growth and change hormone levels in adult rats.

Latanoprost can make eyelashes longer, thicker, and darker.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

The research found how GPCR Class A Rhodopsin receptors are related and suggested possible substances they interact with.

Herbal compounds like ricinoleic acid, quercetin-3-O-rutinoside, and hinokiflavone may be safe and effective for treating hair loss.